U.S. Markets closed

Celsion Corporation (CLSN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.56+0.03 (+1.96%)
At close: 4:00PM EDT
People also watch
CYCCIMUCDCTHAVEOAEZS
  • B
    Bob
    Bob
    Only thing holding this down is funding...Otherwise, with amazingly low capitalization, we should be above 10 with where they are in trials...Funding or partnership announcement and we head quickly over 5 bucks.
  • J
    Joeblo
    Joeblo
    The MM's are busy.. Wonder what the price of the next stock offering will be ??
  • S
    Samantha
    Samantha
    CLSN has just seen the last of the selling. Looks like a potential push higher is in store. Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from Awe-Som.e.Sto-cks..
  • L
    Leon
    Leon
    CLSN is going to rocket next week
  • L
    Lauren
    Lauren
    Very difficult to see CLSN not making a big run north. Yo you should really check out awe-some*sto-cks, they seem on point with their stocks.
  • G
    Grace
    Grace
    Is it time to make a move on CLSN? Yo you should really check out awe-some*sto-cks, they seem on point with their stocks.
  • y
    yuohblpjhvx
    yuohblpjhvx

    Are you sick of getting blasted every day by the sloppy markets. Make sure you sign up to the dork now so you can stop the pain. Details at https://greatprofit12.blogspot.in/

    Penny Stocks
    greatprofit12.blogspot.in
  • J
    Jarred
    Jarred

    www.PennySt0ckl0l.org is one of the best “alerts” services I have found. Just sign up and watch from the sidelines, you will see!

    Loading...
    www.PennySt0ckl0l.org
  • H
    Haley
    Haley
    Is it time to make a move on CLSN? the other week Awe.Som.e.Sto-cks. alerted this company i think. google them .
  • A
    Anonymous
    Anonymous

    SLNO (MC $25 M) BLOCKBUSTER in Phase 3 /Rare Disease +Orphan Status /$2+ BILLION Market /NO Debt = REAL Unknown low float stock with 1000% upside Potential and more .Next billion dollar rare disease company like SRPT here .GLTA

    Soleno therapeutics (SLNO)

    Market Cap $25 Million
    Cash: $8 Million
    Price $0.51

    Shares Out: 47.6 Million ( 36 Million shares held by Insiders & Institutions)

    Initiating Coverage June 26, 2017
    http://www.lifescicapital.com/wp-content/uploads/Soleno.pdf

    •Company expects to initiate pivotal Phase III clinical trial by year-end 2017; will take approximately 9-12 months to complete

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017.

    Market Opportunity for PWS is Substantial.

    While the lack of approved treatments for PWS alone make it difficult to assess the market, sales of Pfizer’s (NYSE: PFE)
    Genotrop in (somatropin) can provide some insight despite being indicate for PWS, in addition to, growth failure due to growth hormone deficiency(GHD),Turner syndrome,idiopathic short stature,and small for gestational age.This product achieved its highest revenue in 2008,with worldwide sales of approximately $900 million.While somatropin has been proven to improve growth and body composition, it does not affect the key disease component of hyperphagia and use is associated with substantial risk. Soleno is developing DCCR for the treatment of PWS,to help address the unmet need of this patient population. To assess the potential of DCCR for PWS, we performed a scenario analysis, which indicates that annual sales could be in the range of $1.1 billion given a moderate price point and 50% market penetrance.

  • R
    Robert
    Robert
    So does Cytx have the same product as CLSN????
  • R
    Robert
    Robert
    CYTX The company also provides ATI-0918, a liposomal encapsulation of doxorubicin for use in treating breast cancer, ovarian cancer, multiple myeloma, and Kaposi’s Sarcoma; Taken from their profile description....
  • J
    Joeblo
    Joeblo
    Yahoo
    News, email and search are just the beginning. Discover more every day. Find your yodel.
    www.yahoo.com
  • R
    Robert
    Robert
    How can a company have "CYTX" have the same product as CLSN a liposomal encapsulation of doxorubicin .
  • W
    Wendy
    Wendy
    Bought this stock at 1.20s. I want to see a buyout, Let's do it
  • m
    madqed
    madqed
    Oh boy, a run up prior to earnings release. Have we ever seen this before for CLSN? Have we ever seen a corresponding drop after the release?
  • T
    TheWind
    TheWind
    Sold my position avg of 1.42. Overall, left with a small gain from trades over past month. May get back, but will wait two months to reassess. Good luck.
  • T
    TheWind
    TheWind
    Nice comeback. I thought I got trapped into a longer holding period than I wanted. As noted, in at 1.53 last week. I plan on holding for a little longer. Perhaps something is really cooking here. Like I said, the company appears to be going in a slightly different direction - hopefully, this translates into a sale or partnership. I realize they've been the kings of dilution last several years, but that path is worn out. Hell, even $50M outright sale would be fantastic at this point. Good luck.
  • C
    Carr
    Carr
    T0pMarketGaIners.c0m is one of the best “alerts” services I have found. Just sign up and watch from the sidelines, you will see!
  • A
    Abigail
    Abigail
    Perhaps a short-term pull back is more likely before the next rally on CLSN? have you guys heard of awe*some*sto-ck*s. i started receiving their allerts and so far i am happy.